X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE STERLING BIOTECH SUVEN LIFE/
STERLING BIOTECH
 
P/E (TTM) x 16.9 -0.4 - View Chart
P/BV x 3.7 0.0 26,654.9% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 SUVEN LIFE   STERLING BIOTECH
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
STERLING BIOTECH
Dec-13
SUVEN LIFE/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs25111 2,388.6%   
Low Rs1553 4,558.8%   
Sales per share (Unadj.) Rs49.126.8 183.3%  
Earnings per share (Unadj.) Rs9.7-15.0 -65.0%  
Cash flow per share (Unadj.) Rs11.4-5.5 -208.5%  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs60.354.9 109.9%  
Shares outstanding (eoy) m127.28267.87 47.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.10.3 1,593.1%   
Avg P/E ratio x20.9-0.5 -4,493.5%  
P/CF ratio (eoy) x17.8-1.3 -1,400.0%  
Price / Book Value ratio x3.40.1 2,657.4%  
Dividend payout %15.40-   
Avg Mkt Cap Rs m25,8251,862 1,387.2%   
No. of employees `0001.11.4 79.2%   
Total wages/salary Rs m613547 112.1%   
Avg. sales/employee Rs Th5,832.65,303.3 110.0%   
Avg. wages/employee Rs Th571.5403.8 141.5%   
Avg. net profit/employee Rs Th1,153.8-2,959.0 -39.0%   
INCOME DATA
Net Sales Rs m6,2537,181 87.1%  
Other income Rs m23343 546.2%   
Total revenues Rs m6,4857,223 89.8%   
Gross profit Rs m1,982947 209.3%  
Depreciation Rs m2132,543 8.4%   
Interest Rs m464,377 1.1%   
Profit before tax Rs m1,955-5,931 -33.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718-1,924 -37.3%   
Profit after tax Rs m1,237-4,007 -30.9%  
Gross profit margin %31.713.2 240.4%  
Effective tax rate %36.732.4 113.2%   
Net profit margin %19.8-55.8 -35.5%  
BALANCE SHEET DATA
Current assets Rs m5,62214,335 39.2%   
Current liabilities Rs m1,16849,809 2.3%   
Net working cap to sales %71.2-494.0 -14.4%  
Current ratio x4.80.3 1,673.1%  
Inventory Days Days81403 20.2%  
Debtors Days Days36171 21.1%  
Net fixed assets Rs m3,32555,432 6.0%   
Share capital Rs m127268 47.5%   
"Free" reserves Rs m7,54713,935 54.2%   
Net worth Rs m7,67414,701 52.2%   
Long term debt Rs m149,478 0.1%   
Total assets Rs m9,13573,988 12.3%  
Interest coverage x43.2-0.4 -12,177.9%   
Debt to equity ratio x00.6 0.3%  
Sales to assets ratio x0.70.1 705.2%   
Return on assets %14.00.5 2,804.2%  
Return on equity %16.1-27.3 -59.1%  
Return on capital %26.0-6.4 -405.1%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m5,0661,860 272.4%   
Fx outflow Rs m2,00125 8,040.2%   
Net fx Rs m3,0651,835 167.0%   
CASH FLOW
From Operations Rs m6991,719 40.7%  
From Investments Rs m-6-3,148 0.2%  
From Financial Activity Rs m-5771,426 -40.5%  
Net Cashflow Rs m116-3 -3,420.6%  

Share Holding

Indian Promoters % 63.4 33.9 187.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 9.9 -  
ADR/GDR % 0.0 16.9 -  
Free float % 36.5 39.3 92.9%  
Shareholders   37,287 21,482 173.6%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   DR. REDDYS LAB  PIRAMAL ENTERPRISES  NATCO PHARMA  SUN PHARMA  PFIZER  

Compare SUVEN LIFE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Over 450 Points Lower; IT and Energy Stocks Witness Selling(Closing)

Share markets in India continued their sell-off seen during the day and ended the trading session deep in the red. All sectoral indices traded on a negative note with stocks in the IT sector.

Related Views on News

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

SUVEN LIFE Announces Quarterly Results (4QFY18); Net Profit Up 56.0% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, SUVEN LIFE has posted a net profit of Rs 625 m (up 56.0% YoY). Sales on the other hand came in at Rs 2 bn (up 18.6% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

You Can Buy Select Auto Stocks Now for Big Long-Term Returns(The 5 Minute Wrapup)

Oct 17, 2018

Irrespective of the earnings hiccups, these businesses be setting new profit records.

This Market Crash could be the Biggest Wealth Creating Opportunity Since 2008(Profit Hunter)

Oct 8, 2018

While widespread fear is the friend of a value investor, serving up bargain purchases; personal fear is an investor's biggest enemy.

IPO Market Feels the Heat of the Market Crash(Sector Info)

Oct 12, 2018

The sentiments in primary market have also deteriorated amid the stock market correction. Most listed IPOs of 2018 are trading below their issue price.

Even If IL&FS Group Brought This Correction, this is Right Time to Buy & Sit Tight!(Chart Of The Day)

Oct 12, 2018

Even if IL&FS is the culprit, it may turn out to be a hero if you buy right and sit tight.

ICICI Prudential Manufacture In India Fund: A Make In India Prodigy, Should You Invest?(Outside View)

Oct 8, 2018

PersonalFN briefly explains if you should be investing in the NFO: ICICI Prudenetial Manufacture in India Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Oct 19, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS